These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 27903858)

  • 1. Taking cancer drug screening very personally.
    Castro CM
    Sci Transl Med; 2016 Nov; 8(367):367ec190. PubMed ID: 27903858
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro assays in preclinical antineoplastic drug screening.
    Weisenthal LM
    Semin Oncol; 1981 Dec; 8(4):362-76. PubMed ID: 7034203
    [No Abstract]   [Full Text] [Related]  

  • 3. [Molecular targeting screening of antineoplastic agents].
    Gan To Kagaku Ryoho; 2002 Mar; 29 Suppl 2():255-415. PubMed ID: 11949661
    [No Abstract]   [Full Text] [Related]  

  • 4. The 15th result of screening for antineoplastic agents.
    Yamori T; Uehara Y; Fukazawa H; Yoshida M; Imoto M; Kiyomiya H; Mashima T; Manakami T; Kawata M; Nagata H; Dan S; Matsuura M; Kakeya H; Tomita A
    Gan To Kagaku Ryoho; 2013 Apr; 40 Suppl 1():116-47. PubMed ID: 24171229
    [No Abstract]   [Full Text] [Related]  

  • 5. Preclinical screening of anticancer drugs using infrared (IR) microspectroscopy.
    Hughes C; Clemens G; Baker MJ
    Trends Biotechnol; 2015 Aug; 33(8):429-30. PubMed ID: 25869233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical screening methods in cancer.
    Kumar S; Bajaj S; Bodla RB
    Indian J Pharmacol; 2016; 48(5):481-486. PubMed ID: 27721530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of random screening of possible antineoplastic agents in Japan using mouse cancer. 3].
    Gan To Kagaku Ryoho; 1984 Sep; 11(9 Pt 2):1899-2096. PubMed ID: 6497404
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of random screening of antineoplastic agents in Japan. 5].
    Tsukagoshi S; Tashiro T; Tsuruo T; Inaba M
    Gan To Kagaku Ryoho; 1991 Apr; 18(5):677-919. PubMed ID: 2024981
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening and evaluation of anticancer agents.
    Zee-Cheng RK; Cheng CC
    Methods Find Exp Clin Pharmacol; 1988 Feb; 10(2):67-101. PubMed ID: 3283480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening at the National Cancer Institute.
    Goldin A; Venditti JM; Carter SK
    Natl Cancer Inst Monogr; 1977 Mar; (45):37-48. PubMed ID: 337155
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer chemotherapy screening data. VIII.
    LEITER J
    Cancer Res; 1960 Nov; 20(10)Pt 2():1-1011. PubMed ID: 13760603
    [No Abstract]   [Full Text] [Related]  

  • 12. Utilization of metabolic activation for in vitro screening of potential antineoplastic agents.
    Meltz ML; Winters DW
    Cancer Treat Rep; 1979; 63(11-12):1795-801. PubMed ID: 526914
    [No Abstract]   [Full Text] [Related]  

  • 13. PRESERVATION FOR BIOCHEMICAL DRUG SCREENING.
    HENDERSON IW; BICKIS IJ
    Surg Forum; 1963; 14():127-8. PubMed ID: 14064479
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ministry of Education Group on Special Comprehensive Cancer Study: Report by the special committee on antineoplastic agent screening].
    Gan To Kagaku Ryoho; 1987 Jan; 14(1 Pt 2):227-361. PubMed ID: 3813570
    [No Abstract]   [Full Text] [Related]  

  • 15. Virtual screening strategies: recent advances in the identification and design of anti-cancer agents.
    Kumar V; Krishna S; Siddiqi MI
    Methods; 2015 Jan; 71():64-70. PubMed ID: 25171960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Establishment and application of a drug screening model for anti-prostate cancer agents targeting androgen receptor].
    He Y; Liu YG; Ding JW; Li XY; Cen S; Zhou JM
    Yao Xue Xue Bao; 2016 Feb; 51(2):287-93. PubMed ID: 29856583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer cell spheroids for screening of chemotherapeutics and drug-delivery systems.
    Patel NR; Aryasomayajula B; Abouzeid AH; Torchilin VP
    Ther Deliv; 2015; 6(4):509-20. PubMed ID: 25996047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted agents: how to select the winners in preclinical and early clinical studies?
    Goodwin R; Giaccone G; Calvert H; Lobbezoo M; Eisenhauer EA
    Eur J Cancer; 2012 Jan; 48(2):170-8. PubMed ID: 22093946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell spheroids: the new frontiers in in vitro models for cancer drug validation.
    Chatzinikolaidou M
    Drug Discov Today; 2016 Sep; 21(9):1553-1560. PubMed ID: 27371506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficiency of antitumor screening relative to activity criteria.
    Paull K; Hodes L; Simon RM
    J Natl Cancer Inst; 1986 Jun; 76(6):1137-42. PubMed ID: 3458950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.